However, investors should note that the net income was boosted by a one-time $31.6 million gain from biological assets. Two years ago, Aurora Cannabis disclosed plans to focus on the higher-margin ...
Aurora Cannabis has transformed its margins ... the back of woeful financial results across the sector and a lack of investor interest. As U.S. legalization continues to get kicked down the ...
However, investors should note that the net income was boosted by a one-time $31.6 million gain from biological assets. Two years ago, Aurora Cannabis disclosed plans to focus on the higher-margin ...
Testing for cannabis is making it increasingly harder for maritime companies to hire employees . Pre-employment drug tests have been a staple in the ...
Aurora Cannabis's stock performance and investor reactions to the operational update may be observed on the NYSE under the ticker ACB following this announcement. In other recent news, Aurora ...
Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 3 undervalued stocks in the Pharmaceuticals industry for Monday, March 10, 2025. Let’s take ...
Let's dive into two top Canadian cannabis stocks and where they may be headed from here (given the recent moves in this ...
Many investors are drawn to cannabis stocks due ... a P/E ratio of -3.11 and a beta of 2.07. Aurora Cannabis Inc., together with its subsidiaries, produces, distributes, and sells cannabis and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results